Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 20, 2023 Filed Sep 28, 2023 00:50 UTC Amendment |
Lapidus StanleyDirector
|
SaleCommon stock | 412 | $1.44 | $593.28 |
DisclosureSEC source: 0001062993-23-018551 · form4a.xml · nonDerivative · entry 2 Lapidus Stanley · CIK 0001678195 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 131,639 F1 · kind: Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock. F2 · balance_after: Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023. F3 · ownership.direct: The reported sales of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023. Read SEC document |
| September 20, 2023 Filed Sep 28, 2023 00:50 UTC Amendment |
Lapidus StanleyDirector
|
SaleCommon stock | 3,405 | $1.45 | $4,937.25 |
DisclosureSEC source: 0001062993-23-018551 · form4a.xml · nonDerivative · entry 1 Lapidus Stanley · CIK 0001678195 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 132,051 F1 · kind: Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock. F2 · balance_after: Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023. F3 · ownership.direct: The reported sales of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023. Read SEC document |
| January 31, 2023 Filed Feb 3, 2023 02:11 UTC |
Sparks Ronald MDirector
|
GrantEmployee stock option (right to buy) · Derivative | 175,000 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001062993-23-002047 · form4.xml · derivative · entry 1 Sparks Ronald M · CIK 0001665394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common stock · 175,000 shares Expires 2033-01-31 F1 · derivative.exercise_date: One third of the option vests on March 31, 2023; the balance vests in eight equal quarterly installments, starting June 30, 2023. Read SEC document |
| January 31, 2023 Filed Feb 3, 2023 01:42 UTC |
White DebraDirector
|
GrantEmployee stock option (right to buy) · Derivative | 175,000 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001062993-23-002041 · form4.xml · derivative · entry 1 White Debra · CIK 0001859882 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common stock · 175,000 shares Expires 2033-01-31 F1 · derivative.exercise_date: One third of the option vests on March 31, 2023; the balance vests in eight equal quarterly installments, starting June 30, 2023. Read SEC document |
| January 31, 2023 Filed Feb 3, 2023 01:40 UTC |
SOKOLOV JACQUE JDirector
|
GrantEmployee stock option (right to buy) · Derivative | 175,000 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001062993-23-002039 · form4.xml · derivative · entry 1 SOKOLOV JACQUE J · CIK 0001282803 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common stock · 175,000 shares Expires 2033-01-31 F1 · derivative.exercise_date: One third of the option vests on March 31, 2023; the balance vests in eight equal quarterly installments, starting June 30, 2023. Read SEC document |
| January 31, 2023 Filed Feb 3, 2023 01:39 UTC |
Lapidus StanleyDirector
|
GrantEmployee stock option (right to buy) · Derivative | 175,000 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001062993-23-002038 · form4.xml · derivative · entry 1 Lapidus Stanley · CIK 0001678195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common stock · 175,000 shares Expires 2033-01-31 F1 · derivative.exercise_date: One third of the option vests on March 31, 2023; the balance vests in eight equal quarterly installments, starting June 30, 2023. Read SEC document |
| January 31, 2023 Filed Feb 3, 2023 01:38 UTC |
Cox James LDirector
|
GrantEmployee stock option (right to buy) · Derivative | 175,000 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001062993-23-002036 · form4.xml · derivative · entry 1 Cox James L · CIK 0001665442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common stock · 175,000 shares Expires 2033-01-31 F1 · derivative.exercise_date: One third of the option vests on March 31, 2023; the balance vests in eight equal quarterly installments, starting June 30, 2023. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 23:08 UTC |
PAVmed Inc.10% owner
|
OtherCommon Stock | 1,479,326 | $1.84 | $2,719,444.99 |
DisclosureSEC source: 0001062993-22-023250 · form4.xml · nonDerivative · entry 5 PAVmed Inc. · CIK 0001624326 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,483,475 F1 · kind: Issuance of common stock by the Issuer to the Reporting Person in satisfaction of a commercial agreement. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 23:08 UTC |
PAVmed Inc.10% owner
|
OtherCommon Stock | 331,210 | $1.66 | $550,007.33 |
DisclosureSEC source: 0001062993-22-023250 · form4.xml · nonDerivative · entry 4 PAVmed Inc. · CIK 0001624326 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,004,149 F1 · kind: Issuance of common stock by the Issuer to the Reporting Person in satisfaction of a commercial agreement. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 23:08 UTC |
PAVmed Inc.10% owner
|
OtherCommon Stock | 221,952 | $2.48 | $549,997.06 |
DisclosureSEC source: 0001062993-22-023250 · form4.xml · nonDerivative · entry 3 PAVmed Inc. · CIK 0001624326 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,672,939 F1 · kind: Issuance of common stock by the Issuer to the Reporting Person in satisfaction of a commercial agreement. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 23:08 UTC |
PAVmed Inc.10% owner
|
OtherCommon Stock | 197,656 | $2.78 | $549,997.59 |
DisclosureSEC source: 0001062993-22-023250 · form4.xml · nonDerivative · entry 2 PAVmed Inc. · CIK 0001624326 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,450,987 F1 · kind: Issuance of common stock by the Issuer to the Reporting Person in satisfaction of a commercial agreement. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 23:08 UTC |
PAVmed Inc.10% owner
|
OtherCommon stock | 1,145,086 | $1.84 | $2,105,011.59 |
DisclosureSEC source: 0001062993-22-023250 · form4.xml · nonDerivative · entry 1 PAVmed Inc. · CIK 0001624326 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,253,331 F1 · kind: Issuance of common stock by the Issuer to the Reporting Person in satisfaction of a commercial agreement. Read SEC document |
| November 30, 2022 Filed Apr 13, 2023 22:09 UTC Amendment |
PAVmed Inc.10% owner
|
OtherCommon Stock | 1,479,326 | $1.84 | $2,719,444.99 |
DisclosureSEC source: 0001062993-23-009156 · form4a.xml · nonDerivative · entry 5 PAVmed Inc. · CIK 0001624326 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,302,420 F1 · kind: Issuance of common stock by the Issuer to the Reporting Person in satisfaction of a commercial agreement. F2 · balance_after: This Form 4 Amendment is being filed for the sole purpose of correcting the Amount of Securities Beneficially Owned Following Reported Transactions in Column 5 of Table I. In every other regard, this Form 4/A is identical to the Form 4 filed on December 2, 2022. Read SEC document |
| November 30, 2022 Filed Apr 13, 2023 22:09 UTC Amendment |
PAVmed Inc.10% owner
|
OtherCommon Stock | 331,210 | $1.66 | $550,007.33 |
DisclosureSEC source: 0001062993-23-009156 · form4a.xml · nonDerivative · entry 4 PAVmed Inc. · CIK 0001624326 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,823,094 F1 · kind: Issuance of common stock by the Issuer to the Reporting Person in satisfaction of a commercial agreement. F2 · balance_after: This Form 4 Amendment is being filed for the sole purpose of correcting the Amount of Securities Beneficially Owned Following Reported Transactions in Column 5 of Table I. In every other regard, this Form 4/A is identical to the Form 4 filed on December 2, 2022. Read SEC document |
| November 30, 2022 Filed Apr 13, 2023 22:09 UTC Amendment |
PAVmed Inc.10% owner
|
OtherCommon Stock | 221,952 | $2.48 | $549,997.06 |
DisclosureSEC source: 0001062993-23-009156 · form4a.xml · nonDerivative · entry 3 PAVmed Inc. · CIK 0001624326 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,491,884 F1 · kind: Issuance of common stock by the Issuer to the Reporting Person in satisfaction of a commercial agreement. F2 · balance_after: This Form 4 Amendment is being filed for the sole purpose of correcting the Amount of Securities Beneficially Owned Following Reported Transactions in Column 5 of Table I. In every other regard, this Form 4/A is identical to the Form 4 filed on December 2, 2022. Read SEC document |
| November 30, 2022 Filed Apr 13, 2023 22:09 UTC Amendment |
PAVmed Inc.10% owner
|
OtherCommon Stock | 197,656 | $2.78 | $549,997.59 |
DisclosureSEC source: 0001062993-23-009156 · form4a.xml · nonDerivative · entry 2 PAVmed Inc. · CIK 0001624326 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,269,932 F1 · kind: Issuance of common stock by the Issuer to the Reporting Person in satisfaction of a commercial agreement. F2 · balance_after: This Form 4 Amendment is being filed for the sole purpose of correcting the Amount of Securities Beneficially Owned Following Reported Transactions in Column 5 of Table I. In every other regard, this Form 4/A is identical to the Form 4 filed on December 2, 2022. Read SEC document |
| November 30, 2022 Filed Apr 13, 2023 22:09 UTC Amendment |
PAVmed Inc.10% owner
|
OtherCommon stock | 1,145,086 | $1.84 | $2,105,011.59 |
DisclosureSEC source: 0001062993-23-009156 · form4a.xml · nonDerivative · entry 1 PAVmed Inc. · CIK 0001624326 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,072,276 F1 · kind: Issuance of common stock by the Issuer to the Reporting Person in satisfaction of a commercial agreement. F2 · balance_after: This Form 4 Amendment is being filed for the sole purpose of correcting the Amount of Securities Beneficially Owned Following Reported Transactions in Column 5 of Table I. In every other regard, this Form 4/A is identical to the Form 4 filed on December 2, 2022. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 15:46 UTC |
Lapidus StanleyDirector
|
SaleCommon stock | 16,864 | $1.70 | $28,668.80 |
DisclosureSEC source: 0001062993-22-019850 · form4.xml · nonDerivative · entry 2 Lapidus Stanley · CIK 0001678195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,456 F1 · kind: Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock. F2 · balance_after: Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which will vest September 20, 2023. Under the plan, unvested shares are subject to forfeiture if the requisite service period is not completed. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 15:46 UTC |
Lapidus StanleyDirector
|
SaleCommon stock | 17,000 | $1.71 | $29,013.90 |
DisclosureSEC source: 0001062993-22-019850 · form4.xml · nonDerivative · entry 1 Lapidus Stanley · CIK 0001678195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,320 F1 · kind: Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock. F2 · balance_after: Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which will vest September 20, 2023. Under the plan, unvested shares are subject to forfeiture if the requisite service period is not completed. Read SEC document |
| August 02, 2022 Filed Aug 2, 2022 20:41 UTC |
White DebraDirector
|
GrantEmployee stock option (right to buy) · Derivative | 80,000 | $0.00 Strike: $2.95 | $0.00 |
DisclosureSEC source: 0001062993-22-017088 · form4.xml · derivative · entry 1 White Debra · CIK 0001859882 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common stock · 80,000 shares Expires 2032-08-02 F1 · derivative.exercise_date: The option vests in 12 quarterly installments, with first installment vesting September 30, 2022. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 20:50 UTC |
Gordon Michael AdamGeneral Counsel
|
GrantEmployee stock option (right to buy) · Derivative | 200,000 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001062993-22-014563 · form4.xml · derivative · entry 1 Gordon Michael Adam · CIK 0001932934 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common stock · 200,000 shares Expires 2032-06-07 F1 · derivative.exercise_date: The option vests in 12 quarterly installments, with first installment vesting June 30, 2022. Read SEC document |
| February 18, 2022 Filed Feb 24, 2022 01:24 UTC |
Angagaw AsterDirector
|
GrantEmployee stock option (right to buy) · Derivative | 59,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001062993-22-005491 · form4.xml · derivative · entry 1 Angagaw Aster · CIK 0001784557 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,000 Underlying: Common stock · 59,000 shares Expires 2032-02-18 F1 · derivative.exercise_date: The option vests in 12 quarterly installments, with first installment vesting March 31, 2022. Read SEC document |
| February 18, 2022 Filed Feb 24, 2022 01:23 UTC |
Lapidus StanleyDirector
|
GrantEmployee stock option (right to buy) · Derivative | 59,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001062993-22-005490 · form4.xml · derivative · entry 1 Lapidus Stanley · CIK 0001678195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,000 Underlying: Common stock · 59,000 shares Expires 2032-02-18 F1 · derivative.exercise_date: The option vests in 12 quarterly installments, with first installment vesting March 31, 2022. Read SEC document |
| February 18, 2022 Filed Feb 24, 2022 01:18 UTC |
Cox James LDirector
|
GrantEmployee stock option (right to buy) · Derivative | 59,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001062993-22-005487 · form4.xml · derivative · entry 1 Cox James L · CIK 0001665442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,000 Underlying: Common stock · 59,000 shares Expires 2032-02-18 F1 · derivative.exercise_date: The option vests in 12 quarterly installments, with first installment vesting March 31, 2022. Read SEC document |
| February 18, 2022 Filed Feb 24, 2022 01:17 UTC |
Sparks Ronald MDirector
|
GrantEmployee stock option (right to buy) · Derivative | 59,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001062993-22-005485 · form4.xml · derivative · entry 1 Sparks Ronald M · CIK 0001665394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,000 Underlying: Common stock · 59,000 shares Expires 2032-02-18 F1 · derivative.exercise_date: The option vests in 12 quarterly installments, with first installment vesting March 31, 2022. Read SEC document |
| February 18, 2022 Filed Feb 24, 2022 01:13 UTC |
Aklog LishanDirector · Chief Executive Officer
|
GrantEmployee stock option (right to buy) · Derivative | 75,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001062993-22-005482 · form4.xml · derivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common stock · 75,000 shares Expires 2032-02-18 F1 · derivative.exercise_date: The option vests in 12 quarterly installments, with first installment vesting March 31, 2022. Read SEC document |
| February 18, 2022 Filed Feb 24, 2022 01:15 UTC |
MCGRATH DENNIS MChief Financial Officer
|
GrantEmployee stock option (right to buy) · Derivative | 50,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001062993-22-005483 · form4.xml · derivative · entry 1 MCGRATH DENNIS M · CIK 0001269340 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common stock · 50,000 shares Expires 2032-02-18 F1 · derivative.exercise_date: The option vests in 12 quarterly installments, with first installment vesting March 31, 2022. Read SEC document |
| February 18, 2022 Filed Feb 24, 2022 16:09 UTC |
SOKOLOV JACQUE JDirector
|
GrantEmployee stock option (right to buy) · Derivative | 59,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001062993-22-005542 · form4.xml · derivative · entry 1 SOKOLOV JACQUE J · CIK 0001282803 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,000 Underlying: Common stock · 59,000 shares Expires 2032-02-18 F1 · derivative.exercise_date: The option vests in 12 quarterly installments, with first installment vesting March 31, 2022. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 01:07 UTC |
MCGRATH DENNIS MChief Financial Officer
|
GrantCommon stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-000909 · form4.xml · nonDerivative · entry 1 MCGRATH DENNIS M · CIK 0001269340 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 624,400 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of January 7, 2025. Such restricted stock is subject to forfeiture if the requisite service period is not completed. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 01:06 UTC |
Aklog LishanDirector · Chief Executive Officer
|
GrantCommon stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-000907 · form4.xml · nonDerivative · entry 1 Aklog Lishan · CIK 0001665074 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 624,400 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of January 7, 2025. Such restricted stock is subject to forfeiture if the requisite service period is not completed. Read SEC document |
| October 18, 2021 Filed Oct 20, 2021 21:05 UTC |
Sparks Ronald MDirector
|
GrantCommon stock | 84,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-009744 · form4.xml · nonDerivative · entry 1 Sparks Ronald M · CIK 0001665394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,660 Read SEC document |
| October 18, 2021 Filed Oct 20, 2021 21:04 UTC |
PAVmed Inc.10% owner
|
PurchaseCommon stock | 571,428 | $14.00 | $7,999,992.00 |
DisclosureSEC source: 0001062993-21-009743 · form4.xml · nonDerivative · entry 1 PAVmed Inc. · CIK 0001624326 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,927,190 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.